Biotech investors swarm into S.F. after encouraging year / JPMorgan meeting promising venue to make sweet deals

Biotech's annual kickoff conference, which starts today at the Westin St. Francis Hotel in San Francisco, is like a slightly delayed New Year's Eve party, with revelers celebrating the past year's triumphs, resolving to do better in the future while cruising for new relationships. In the Bay Area, the noteworthy deals in play include Amgen's $2.2 billion purchase offer for the Fremont biotech company Abgenix, and Novartis' pending $5.1 billion offer for the pioneering Emeryville biotech company Chiron Corp.

Biotech investors swarm into S.F. after encouraging year / JPMorgan meeting promising venue to make sweet deals

No comments:

Blog Archive